Adipose tissue-derived mesenchymal stem cells as a strategy to improve recovery after stroke

Expert Opinion on Biological Therapy

Volumn 15, Issue 6, 2015, Pages 873-881

  Gutiérrez Fernández, María ^a   Otero Ortega, Laura ^a   Ramos Cejudo, Jaime ^a   Rodríguez Frutos, Berta ^a   Fuentes, Blanca ^a   Díez Tejedor, Exuperio ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Adipose tissue; Hemorrhagic stroke; Ischemic stroke; Mesenchymal stem cells

Indexed keywords

ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PROTECTION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); EXPERIMENTAL MODEL; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; REVIEW; STEM CELL EXPANSION; STROKE PATIENT; ADIPOSE TISSUE; ANIMAL; BRAIN; CONVALESCENCE; CYTOLOGY; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY; PROCEDURES; STROKE; TRANSPLANTATION; TRENDS;

ANIMALIA;

ADIPOSE TISSUE; ANIMALS; BRAIN; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RECOVERY OF FUNCTION; STROKE;

EID: 84929853200     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1517/14712598.2015.1040386     Document Type: Review

References (55)

1. World Health Organization. The top 10 causes of death -Homepage. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/[Last accessed March 2015]
2. Albertson M, Sharma J. Stroke: current concepts. S D Med 2014;67:457-61
3. Qureshi A, Mendelow D, Hanley D. Intracerebral haemorrhage. Lancet 2009;373:1632-44
4. Chang KA, Lee JH, Suh YH. Therapeutic potential of human adiposederived stem cells in neurological disorders. J Pharmacol Sci 2014;126:293-301
5. Parker AM, Katz AJ. Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther 2006;6:567-78
6. Ra JC, Shin IS, Kim SH, et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011;20:1297-308
7. Gutierrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, et al. Effects of intravenous administration of allogeneic bone marrow-And adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther 2013;4:11
8. Gutierrez-Fernández M, Rodríguez-Frutos B, Otero-Ortega L, et al. Adipose tissue-derived stem cells in stroke treatment: from bench to bedside. Discov Med 2013;16:37-43
9. Gutierrez-Fernández M, Fuentes B, Rodríguez-Frutos B, et al. Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke. J Cell Mol Med 2012;16:2280-90
10. Gutierrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, et al. Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct. Proof of concept in rats. J Trans Med 2015;13:46
11. Ikegame Y, Yamashita K, Hayashi S, et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 2011;13:675-85
12. Leu S, Lin YC, Yuen CM, et al. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med 2010;8:63
13. Lin XH, Liu N, Xiao YC, et al. Effects of adipose-derived stem cells transplantation on the neuronal apoptosis and the expression of Bcl-2 and caspase-12 in the brain post focal cerebral ischemia in rats. Chinese J Cell Mol Immunol 2011;27:40-3
14. Erba P, Terenghi G, Kingham PJ. Neural differentiation and therapeutic potential of adipose tissue derived stem cells. Curr Stem Cell Rest 2010;5:153-60
15. Wang JH, Liu N, Du HW, et al. Effects of adipose-derived stem cell transplantation on the angiogenesis and the expression of bFGF and VEGF in the brain post focal cerebral ischemia in rats. J Cell Mol Immunol 2008;24:958-61
16. Matute C, Domercq M, Perez-Samartin A, et al. Protecting white matter from stroke injury. Stroke 2013;44:1204-11
17. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974;2:83-92
18. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-28
19. Kang SK, Lee DH, Bae YC, et al. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003;183:355-66
20. Gutierrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, et al. Stem cells for brain repair and recovery after stroke. Expert Opin Biol Ther 2013;13:1479-83
21. Melief SM, Zwaginga JJ, Fibbe WE, et al. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem cells Trans Med 2013;2:455-63
22. Detante O, Moisan A, Dimastromatteo J, et al. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant 2009;18:1369-79
23. Yang B, Migliati E, Parsha K, et al. Intra-Arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke 2013;44:3463-72
24. Fernandez R, Nardocci G, Navarro C, et al. Neural reflex regulation of systemic inflammation: potential new targets for sepsis therapy. Front Physiol 2014;5:489
25. Wei X, Du Z, Zhao L, et al. IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells 2009;27:478-88
26. Cho YJ, Song HS, Bhang S, et al. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res 2012;90:1794-802
27. Hayashi T, Abe K, Itoyama Y. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 1998;18:887-95
28. Jeon D, Chu K, Lee ST, et al. Neuroprotective effect of a cell-free extract derived from human adipose stem cells in experimental stroke models. Neurobiol Dis 2013;54:414-20
29. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 2011;6:481-92
30. Xin H, Li Y, Cui Y, et al. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 2013;33:1711-15
31. Otero L, Bonilla C, Aguayo C, et al. Intralesional administration of allogeneic bone marrow stromal cells reduces functional deficits after intracerebral hemorrhage. Histol Histopathol 2010;4:453-61
32. Otero L, Zurita M, Bonilla C, et al. Late transplantation of allogeneic bone marrow stromal cells improves neurologic deficits subsequent to intracerebral hemorrhage. Cytotherapy 2011;5:562-71
33. Otero L, Zurita M, Bonilla C, et al. Allogeneic bone marrow stromal cell transplantation after cerebral hemorrhage achieves cell transdifferentiation and modulates endogenous neurogenesis. Cytotherapy 2012;14:34-44
34. Ahn SY, Chang YS, Sung DK, et al. Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage. Stroke 2013;2:497-504
35. Chen J, Tang YX, Liu YM, et al. Transplantation of adipose-derived stem cells is associated with neural differentiation and functional improvement in a rat model of intracerebral hemorrhage. CNS Neurosci Ther 2012;10:847-54
36. Kim JM, Lee ST, Chu K, et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007;1183:43-50
37. Lim MH, Ong WK, Sugii S. The current landscape of adipose-derived stem cells in clinical applications. Expert Rev Mol Med 2014;16:e8 . This review seeks to highlight the clinical applicability of AD-MSC as well as their progress in clinical trials across various medical disciplines.
38. Gao S, Zhao P, Lin C, et al. Differentiation of human adipose-derived stem cells into neuron-like cells which are compatible with photocurable threedimensional scaffolds. Tissue Eng Part A 2014;20:1271-84
39. Keeney M, Deveza L, Yang F. Programming stem cells for therapeutic angiogenesis using biodegradable polymeric nanoparticles. J Vis Exp 2013;79:e50736
40. Moriyama M, Moriyama H, Ueda A, et al. Human adipose tissue-derived multilineage progenitor cells exposed to oxidative stress induce neurite outgrowth in PC12 cells through p38 MAPK signaling. BMC Cell Biol 2012;13:21
41. Shen CC, Yang YC, Chiao MT, et al. Low-level laser stimulation on adipose-Tissue-derived stem cell treatments for focal cerebral ischemia in rats. Evid Based Complement Alternat Med 2013;2013:594906
42. Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003;75:389-97
43. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hemato 2004;32:414-25
44. Du G, Liu Y, Dang M, et al. Comparison of administration routes for adipose-derived stem cells in the treatment of middle cerebral artery occlusion in rats. Acta Histochem 2014;116:1075-84
45. Gutierrez M, Merino JJ, Alonso de Lecinana M, et al. Cerebral protection, brain repair, plasticity and cell therapy in ischemic stroke. Cerebrovasc Dis 2009;27:177-86
46. Chan TM, Harn HJ, Lin HP, et al. The use of ADSCs as a treatment for chronic stroke. Cell Transplant 2014;23:541-7
47. Shen LH, Li Y, Chen J, et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007;27:6-13
48. Vasconcelos Dos Santos A, Costa Reis J, Diaz Paredes B, et al. Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res 2010;1306:149-58
49. ClinicalTrials.gov -Homepage. Available from: htpp//:www.clinicaltrials.gov [Last accessed March 2015]
50. Feng Y, Zhu M, Dangelmajer S, et al. Hypoxia-cultured human adipose-derived mesenchymal stem cells are nononcogenic and have enhanced viability, motility, and tropism to brain cancer. Cell Death Dis 2014;5:e1567
51. Wei HJ, Zeng R, Lu JH, et al. Adipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 production. Oncotarget 2015. [Epub ahead of print]
52. Freese KE, Kokai L, Edwards RP, et al. Adipose-derived stems cells and their role in human cancer development, growth, progression, and metastasis: a systematic review. Cancer Res 2015;75(7):1161-8
53. Sozmen EG, Kolekar A, Havton LA, et al. A white matter stroke model in the mouse: axonal damage, progenitor responses and MRI correlates. J Neurosci Meth 2009;180:261-72
54. Rosenzweig S, Carmichael ST. Age-dependent exacerbation of white matter stroke outcomes: a role for oxidative damage and inflammatory mediators. Stroke 2013;44:2579-86
55. Ramos-Cejudo J, Gutierrez-Fernández M, Otero-Ortega L, et al. Brain-derived neurotrophic factor administration mediated oligodendrocyte differentiation and myelin formation in subcortical ischemic stroke. Stroke 2015;46:221-8